HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kexin Liu Selected Research

Jelleine I

3/2021Multiple action mechanism and in vivo antimicrobial efficacy of antimicrobial peptide Jelleine-I.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kexin Liu Research Topics

Disease

42Neoplasms (Cancer)
01/2022 - 03/2003
37Inflammation (Inflammations)
12/2021 - 11/2013
11Breast Neoplasms (Breast Cancer)
10/2020 - 09/2009
10Acute Kidney Injury (Acute Renal Failure)
09/2022 - 11/2012
10Cholestasis
09/2021 - 04/2015
9Non-alcoholic Fatty Liver Disease
08/2022 - 12/2013
7Body Weight (Weight, Body)
06/2020 - 01/2015
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2016
7Reperfusion Injury
12/2019 - 11/2013
6Liver Cirrhosis (Hepatic Cirrhosis)
10/2020 - 04/2015
6Fibrosis (Cirrhosis)
01/2020 - 02/2017
5Wounds and Injuries (Trauma)
01/2022 - 01/2015
5Infections
01/2021 - 04/2017
5Lung Neoplasms (Lung Cancer)
01/2020 - 09/2013
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 01/2018
4Hepatocellular Carcinoma (Hepatoma)
09/2021 - 01/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2017
4Atherosclerosis
10/2019 - 01/2014
4Hypoxia (Hypoxemia)
03/2019 - 10/2015
4Insulin Resistance
02/2019 - 07/2017
4Hepatitis
03/2013 - 07/2008
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 01/2015
3Obesity
10/2020 - 01/2015
3Rheumatoid Arthritis
01/2020 - 01/2016
3Lymphoma (Lymphomas)
01/2020 - 07/2017
3Necrosis
12/2018 - 06/2009
3Liver Diseases (Liver Disease)
04/2018 - 12/2017
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2017 - 01/2015
3Colonic Neoplasms (Colon Cancer)
01/2014 - 01/2014
2Neoplasm Metastasis (Metastasis)
01/2022 - 11/2014
2Intestinal Diseases (Diseases, Intestinal)
12/2021 - 09/2010
2Acute Liver Failure (Fulminant Hepatic Failure)
11/2021 - 02/2015
2Diabetes Mellitus
01/2021 - 02/2015
2Hypercholesterolemia
01/2020 - 01/2019
2Idiopathic Pulmonary Fibrosis
01/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

28dioscinIBA
10/2020 - 05/2013
21Pharmaceutical PreparationsIBA
02/2022 - 06/2009
10Interleukin-6 (Interleukin 6)IBA
12/2021 - 12/2015
9Biological ProductsIBA
01/2021 - 09/2010
8Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2010
8JBP 485IBA
03/2019 - 07/2008
7Small Interfering RNA (siRNA)IBA
02/2022 - 07/2015
7Bile Acids and Salts (Bile Acids)IBA
09/2021 - 01/2017
7EnzymesIBA
01/2021 - 11/2016
7Doxorubicin (Adriamycin)FDA LinkGeneric
08/2019 - 05/2013
6Cisplatin (Platino)FDA LinkGeneric
09/2022 - 11/2012
6Messenger RNA (mRNA)IBA
02/2022 - 04/2015
6Therapeutic UsesIBA
01/2022 - 11/2014
6yangoninIBA
09/2021 - 01/2018
6LipidsIBA
09/2021 - 01/2014
6AntioxidantsIBA
06/2020 - 02/2013
4Glycyrrhizic Acid (Glycyrrhizin)IBA
08/2022 - 09/2016
4LuteolinIBA
01/2022 - 01/2014
4Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2015
4SolutionsIBA
10/2020 - 01/2013
4Insulin (Novolin)FDA Link
06/2020 - 02/2015
4CholesterolIBA
01/2020 - 01/2015
4CollagenIBA
01/2020 - 12/2015
4pyrimidineIBA
01/2020 - 01/2018
4catalpolIBA
01/2020 - 01/2018
4Gefitinib (Iressa)FDA Link
12/2018 - 03/2016
4LipopolysaccharidesIBA
12/2018 - 12/2015
4Glucose (Dextrose)FDA LinkGeneric
02/2018 - 02/2015
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2018 - 01/2015
4Docetaxel (Taxotere)FDA Link
09/2016 - 09/2009
4Succinic Acid (Succinate)IBA
01/2016 - 05/2010
4tocophersolanIBA
08/2015 - 05/2010
3Peptides (Polypeptides)IBA
10/2021 - 01/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2021 - 06/2009
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 01/2020
3Triglycerides (Triacylglycerol)IBA
01/2021 - 01/2015
3Streptozocin (Streptozotocin)FDA Link
01/2021 - 02/2015
3ibrutinibIBA
01/2020 - 01/2018
3spebrutinibIBA
01/2020 - 01/2017
3Estrogens (Estrogen)FDA Link
10/2019 - 07/2019
3Thioacetamide (Thioacetamid)IBA
10/2019 - 04/2015
3Acetaminophen (Paracetamol)FDA LinkGeneric
10/2018 - 05/2014
3HMGB1 Protein (HMG1)IBA
03/2018 - 01/2017
3Agammaglobulinaemia Tyrosine KinaseIBA
07/2017 - 01/2017
3polyethylene glycol 1000IBA
01/2016 - 05/2010
3SaponinsIBA
02/2015 - 04/2014
3FlavonoidsIBA
12/2013 - 02/2013
3Poloxamer (Poloxamer 407)IBA
06/2010 - 09/2009
2formononetinIBA
09/2022 - 01/2017
2isoliquiritigenin (GU 17)IBA
02/2022 - 11/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 01/2021
2Inosine Monophosphate (IMP)IBA
01/2022 - 06/2013
2ImipenemFDA Link
01/2022 - 09/2019
2Glutens (Glutelin)IBA
12/2021 - 03/2019
2PolymersIBA
09/2021 - 01/2014
2GlucocorticoidsIBA
01/2021 - 01/2019
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2020 - 12/2019
2Blood Glucose (Blood Sugar)IBA
06/2020 - 02/2015
2rheinIBA
01/2020 - 09/2018
2PyrimidinesIBA
01/2020 - 01/2020
2Organic Anion TransportersIBA
01/2020 - 07/2018
2MicroRNAs (MicroRNA)IBA
01/2020 - 01/2016
2CilastatinFDA Link
01/2020 - 09/2019

Therapy/Procedure

17Therapeutics
01/2022 - 06/2010
12Drug Therapy (Chemotherapy)
10/2020 - 09/2009